[{"Assets_0_Q3_USD":"6264040000.0","CIK":"1048477","CommonStockSharesIssued_0_Q3_shares":"185824253.0","CommonStockSharesOutstanding_0_Q3_shares":"185824253.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"-0.04","EarningsPerShareBasic_3_Q3_USD":"0.77","EarningsPerShareDiluted_1_Q3_USD":"-0.04","EarningsPerShareDiluted_3_Q3_USD":"0.75","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"14899091235.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"169116000.0","NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":"-6652000.0","NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":"141810000.0","NetIncomeLoss_1_Q3_USD":"-6652000.0","NetIncomeLoss_3_Q3_USD":"141810000.0","OfficialName":"BioMarin Pharmaceutical Inc. Common Stock","RevenuesConverted_1_Q3_USD":"505344000.0","RevenuesConverted_3_Q3_USD":"1558501000.0","SP500":null,"Sector":"Health Care","StockholdersEquity_0_Q3_USD":"4568514000.0","Ticker":"BMRN","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"185597000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"192252000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"185597000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"185009000.0","filed":"20221028","footnote":null,"form":"10-Q","fp":"Q3","fy":"2022.0","name":"BIOMARIN PHARMACEUTICAL INC","period":"20220930","qtrs":"0","uom":"USD"}]